Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1417, 2003-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Coronary stenting "highly cost-effective" in MI vs alteplase
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 442, 2003-01 ,pp. :
Access to resources
Recommend
Eptifibatide `highly cost-effective' for coronary stenting
Inpharma, Vol. 1, Iss. 1315, 2001-01 ,pp. :
Eptifibatide `highly cost-effective' for coronary stenting
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 340, 2001-01 ,pp. :
Alteplase cost effective in acute MI vs streptokinase
Inpharma, Vol. 1, Iss. 1366, 2002-01 ,pp. :
Alteplase cost-effective option for acute ischaemic stroke
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 333, 2001-01 ,pp. :